Idexx Laboratories, Inc.

Eugene Regis Krah, Iii

Thomas Patrick O'Connor, Jr

Melissa Jane Beall

Robert L Lawton

Jiayou Liu

Stacey Pazar Huth

Daniel Karl Rieger

Ramaswamy Chandrashekar

Jill Saucier

Hongliang Guo

Ashok P Aiyappa

Philip R Andersen

Brion Mermer

Ku-chuan Hsiao

Marilyn Strong-Townsend

Jesse Buch

Barbara O'Brien

Wendy W Liu

Melissa Jane Beal

Barbara O'Brien Graff

Marylin I Strong-Townsend

Jr Thomas Patrick O'CONNOR

Thomas Patrick O'CONNER

The invention provides methods and compositions for the detection and treatment ofandinfection.

[object Object]

The invention providesantigens that can be used to detectinfected animals regardless of whether the animals have been vaccinated for. The invention also provides compositions and methods for determining the presence ofantigens and antibodies.

antigens that can be used to differentiateinfected animals from animals that have been challenged with, e.g., vaccinated against, are disclosed. The invention also provides compositions and methods for determining the presence ofantigens and antibodies.

The invention provides methods and compositions for the detection of

The invention provides methods and compositions for inhibiting binding of IgE to a high affinity receptor. The methods and compositions are useful in the treatment of allergic diseases and allergy symptoms in mammals.

Methods and compositions for inhibiting binding of IgE to a high affinity receptor

Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.

Feline pancreatic lipase

Isolated nucleic acid molecules having a nucleotide sequence encoding canine pancreatic lipase polypeptides, allelic variants and fragments thereof. Vectors and host cells containing the polynucleotide sequences and methods for expressing the polypeptides. Monoclonal antibodies that specifically binds to the canine pancreatic lipase polypeptides. Cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of canine pancreatic lipase in a biological sample. The methods include using the monoclonal antibodies to specifically bind to canine pancreatic lipase polypeptides. The method includes using standards of recombinant canine pancreatic lipase. Devices and kits for performing methods for detecting canine pancreatic lipase in biological samples.

Methods to determine the presence or amount of canine pancreatic lipase with antibodies

Antibodies that bind canine pancreatic lipase

Growing community of inventors

Freeport, ME, United States of America

Eugene Regis Krah, Iii